Skip to main content
Year archive

TiumBio Co., Ltd. — 2023 filings

All 41 regulatory filings released by TiumBio Co., Ltd. (321550) in 2023, sourced directly from the official regulator.

41 Filings
2023 Period
2023 filings (41)
Filing Released Lang
전환사채(해외전환사채포함)발행후만기전사채취득
Capital/Financing Update
2023-12-28 Korean
증권발행결과(자율공시)
Share Issue/Capital Change
2023-12-28 Korean
주요사항보고서(유상증자결정)
Share Issue/Capital Change
2023-12-20 Korean
주요사항보고서(타법인주식및출자증권양수결정)
M&A Activity
2023-12-20 Korean
전환사채(해외전환사채포함)발행후만기전사채취득
Capital/Financing Update
2023-11-30 Korean
[기재정정]전환사채(해외전환사채포함)발행후만기전사채취득
Capital/Financing Update
2023-11-30 Korean
[기재정정]반기보고서 (2023.06)
Interim / Quarterly Report H1 2023
2023-11-14 Korean
분기보고서 (2023.09)
Interim / Quarterly Report 9M 2023
2023-11-14 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2023-10-26 Korean
증권발행결과(자율공시)
Share Issue/Capital Change
2023-10-23 Korean
주요사항보고서(전환사채권발행결정)
Capital/Financing Update
2023-10-13 Korean
주식매수선택권부여에관한신고
Share Issue/Capital Change
2023-10-13 Korean
전환사채(해외전환사채포함)발행후만기전사채취득
Capital/Financing Update
2023-08-31 Korean
반기보고서 (2023.06)
Interim / Quarterly Report H1 2023
2023-08-14 Korean
본점소재지변경
Regulatory Filings
2023-08-11 Korean
기업설명회(IR)개최
Report Publication Announcement
2023-08-07 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2023-07-31 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2023-07-27 Korean
투자판단관련주요경영사항(임상시험계획변경승인신청)(TU2218 국내 식약처 1/2상 변경승인신청)
Regulatory Filings
2023-05-22 Korean
투자판단관련주요경영사항(임상시험계획변경승인)(면역항암제 TU2218 식약처 임상1/2상 임상시험계획 변경 승인)
Legal Proceedings Report
2023-05-22 Korean
분기보고서 (2023.03)
Interim / Quarterly Report Q1 2023
2023-05-15 Korean
기업설명회(IR)개최
Report Publication Announcement
2023-05-08 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2023-04-17 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2023-04-17 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2023-04-17 Korean
투자판단관련주요경영사항(혈우병 우회인자 TU7710 의 한국 MFDS 임상 1a상 시험계획 (IND) 승인)
Regulatory Filings
2023-04-03 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements
2023-03-29 Korean
주식매수선택권부여에관한신고
Share Issue/Capital Change
2023-03-29 Korean
감사보고서제출
Audit Report / Information FY 2022
2023-03-21 Korean
사업보고서 (2022.12)
Annual Report FY 2022
2023-03-21 Korean
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change
2023-03-14 Korean
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change
2023-03-14 Korean
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change
2023-03-14 Korean
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change
2023-03-14 Korean
주주총회소집결의
Proxy Solicitation & Information Statement
2023-03-14 Korean
주주총회소집공고
Proxy Solicitation & Information Statement
2023-03-14 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement
2023-03-14 Korean
유상증자결정(종속회사의주요경영사항)
Capital/Financing Update
2023-03-08 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release FY 2022
2023-02-14 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2023-01-06 Korean
투자판단관련주요경영사항('TU2670 기술이전 및 공동개발 계약' 관련 마일스톤 기술료 수령)
Regulatory Filings
2023-01-02 Korean